Pain alliance with Evotec

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and APEIRON Biologics AG today announced that they have entered into a collaboration to identify small molecule modulators of DREAM (Downstream Regulatory Element Antagonistic Modulator), a novel target involved in perception of various pain mechanisms.

Press release

Presseaussendung